01302.HK
LifeTech Scientific Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 1.39
+2.59%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.6B | 1.4B | 1.3B | 1.3B | 1.1B |
| Cost of Revenue | 668.6M | 350.7M | 322.3M | 271.5M | 223.4M |
| Gross Profit | 1.9B | 1.0B | 981.4M | 995.6M | 873.9M |
| Operating Expenses | |||||
| R&D Expense | 536.0M | 242.7M | 302.9M | 297.9M | 208.5M |
| SG&A Expense | 1.2B | 608.2M | 504.2M | 414.6M | 347.7M |
| General & Admin Expense | 299.2M | 207.2M | 164.6M | 149.3M | 102.5M |
| Selling & Marketing Expense | 591.4M | 401.8M | 339.6M | 265.3M | 245.2M |
| Other Expenses | 17.6M | (16.5M) | (12.0M) | (100.2M) | (58.2M) |
| Total Operating Expenses | 1.8B | 834.4M | 795.1M | 612.4M | 498.0M |
| Cost and Expenses | 2.4B | 1.2B | 1.1B | 883.9M | 721.4M |
| Operating Income (EBIT) | 177.3M | 184.7M | 186.3M | 383.3M | 375.9M |
| Non-Operating | |||||
| Interest Income | 46.4M | 25.5M | 18.6M | 12.8M | 16.6M |
| Interest Expense | 10.3M | 210.0K | 1.9M | 722.0K | 632.0K |
| Net Interest Income | 36.1M | 25.2M | 16.7M | 12.1M | 16.0M |
| Other Non-Op Income/Expense | (7.2M) | 6.7M | 12.7M | (207.7M) | 2.1M |
| Non-Operating Income (excl Interest) | (63.0M) | (10.7M) | (22.0M) | 207.0M | 6.9M |
| EBT (Pre-Tax Income) | 170.2M | 191.5M | 199.0M | 175.6M | 378.0M |
| Income Tax Expense | 122.7M | 79.1M | 30.5M | 68.1M | 59.3M |
| Bottom Line | |||||
| Net Income | 130.8M | 147.8M | 222.4M | 263.2M | 325.3M |
| Earnings from Cont. Ops | 47.4M | 112.4M | 168.5M | 107.5M | 318.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 130.8M | 147.8M | 222.4M | 263.2M | 325.3M |
| Per Share | |||||
| Basic EPS | HK$0.03 | HK$0.03 | HK$0.05 | HK$0.06 | HK$0.08 |
| Diluted EPS | HK$0.03 | HK$0.03 | HK$0.05 | HK$0.06 | HK$0.07 |
| Revenue Per Share | HK$0.60 | HK$0.31 | HK$0.30 | HK$0.29 | HK$0.26 |
| Shares | |||||
| Basic Shares Outstanding | 4.4B | 4.4B | 4.4B | 4.4B | 4.2B |
| Diluted Shares Outstanding | 4.4B | 4.4B | 4.4B | 4.4B | 4.4B |
| Profitability Metrics | |||||
| EBITDA | 410.6M | 291.7M | 271.9M | 253.5M | 445.8M |
| D&A | 170.2M | 96.3M | 63.5M | 77.2M | 67.1M |
| EBIT | 240.4M | 195.4M | 208.4M | 176.3M | 378.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026